Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure
Crossref DOI link: https://doi.org/10.1208/s12248-016-0026-8
Published Online: 2017-01-09
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herskovitz, Jonathan
Ryman, Josiah
Thway, Theingi
Lee, Stephanie
Zhou, Lei
Chirmule, Narendra
Meibohm, Bernd
Jawa, Vibha
License valid from 2017-01-09